Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
King of Prussia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing immuno-oncology therapeutics based on its proprietary INTASYL® gene-silencing technology, today announced the receipt of a U.S. Notice of Allowance for a patent covering PH-894, further strengthening the Company's intellectual property portfolio. The patent allowance represents a critical milestone in protecting Phio's stra
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-11 7:00 AM EDT | Phio Pharmaceuticals Corp.
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) -
Biotechnology, Pharmaceuticals, Health
2026-08-11 6:30 AM EDT | BioHarvest Sciences Inc.
Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has officially commenced commercial production of its highly anticipated new protein-focused product line. This marks a significant milestone in the Company's product development roadmap and underscores its core focus on revenue gener
2026-08-11 6:00 AM EDT | Restart Life Sciences Corp.
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) - BioHarvest Sciences I
Biotechnology, Pharmaceuticals, Health
2026-08-11 6:00 AM EDT | BioHarvest Sciences Inc.
Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date
Fiscal Q1 2027 includes product-level net revenue from GRAFAPEX™ (treosulfan) for Injection of $4.9 million relative to $3.2 million of GRAFAPEX personnel and infrastructure investments Commercial traction observed to date reinforces Medexus confidence in the growth trajectory of GRAFAPEX Management to host conference call at 8:00 AM Eastern time on Tuesday, August 11, 2026
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-10 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026
Northvale, New Jersey--(Newsfile Corp. - August 10, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that the first quarter financial results of the 2027 fiscal year will be released on Thursday, August 13, 2026. Elite's management will host a live conference call on Friday, August 14th, at 11:30 AM EDT to discuss the company's financial and o
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-10 4:54 PM EDT | Elite Pharmaceuticals, Inc.
Tersis Technologies Files Current Report to Update Corporate Reference Data, Highlighting Shift to Clean-Technology and Circular-Infrastructure Business
Brooksville, Florida--(Newsfile Corp. - August 10, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a clean-technology company focused on transforming waste streams into valuable resources, today announced that it has filed a Current Report through the OTC Markets Disclosure & News Service to formally update its corporate reference record and business description with OTC Markets, licensed reference-data vendors, and financial media outlets. The Current R
Agriculture, Energy, Alternative Energy, Health
2026-08-10 10:58 AM EDT | Tersis Technologies Inc.
Mobile-health Network Solutions Advances AI-Powered Lab Data Analysis to Transform Clinical Decision-Making
Singapore, Singapore--(Newsfile Corp. - August 10, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health ecosystem headquartered in Singapore, today announced the development of a next-generation AI-powered lab data analysis solution designed to help clinicians rapidly interpret complex longitudinal laboratory data and improve patient care outcomes at scale. Developed through its subsidiary Skylink I
2026-08-10 9:00 AM EDT | Mobile-health Network Solutions
Charlotte's Web Welcomes Senate Passage of Hemp Extension Marking Important Progress Toward a Long-Term Federal Hemp Framework
Louisville, Colorado--(Newsfile Corp. - August 10, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a botanical wellness innovation company and the market leader in hemp-derived cannabidiol (CBD) extract wellness products, today welcomed the U.S. Senate's passage of its Continuing Resolution (CR), which would extend current government funding through December 11, 2026, and provide Congress additional time to finish developing a bipartisan federal framework for hemp.
2026-08-10 8:23 AM EDT | Charlotte's Web Holdings, Inc.
TelyRx Announces Second Quarter 2026 Financial Results
Clearwater, Florida--(Newsfile Corp. - August 10, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a technology-enabled healthcare and digital pharmacy platform, today announced financial results for the second quarter ended June 30, 2026. All dollar amounts are expressed in U.S. dollars. Highlights for the Second Quarter of 2026 Revenue increased to $22.7 million, compare
Healthcare and Hospitals, Health
2026-08-10 7:00 AM EDT | TelyRx
Rise Nano Optics Announces Frankfurt Stock Exchange Listing
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that its common shares are now listed and trading on the Frankfurt Stock Exchange
2026-08-10 7:00 AM EDT | Rise Nano Optics Ltd.
Extendicare Announces 2026 Second Quarter Results
Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") today reported results for the three and six months ended June 30, 2026. Second Quarter 2026 Highlights Adjusted EBITDA(1) increased by $28.5 million or 71.7% from Q2 2025 to $68.3 million, driven primarily by contributions from the acquisitions of CBI Home Health and Closing the Gap, as well as continued
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 5:00 PM EDT | Extendicare Inc.
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
King of Prussia, Pennsylvania--(Newsfile Corp. - August 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminat
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 4:05 PM EDT | Phio Pharmaceuticals Corp.
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly revenue increased by 32% to $151.6 million in Q2-2026 as compared to Q2-2025. WELL achieved Adjusted EBITDA(1) of $48.1 million in Q2-2026, a decrease of 3% as compared to Q2-2025, representing an Adjusted EBITDA Margin(1) of 12%. The decrease reflects the impact
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-06 4:00 PM EDT | WELL Health Technologies Corp.
Jones Healthcare Group Expands Integrated Packaging Capabilities With Thermoforming Acquisition
London, Ontario--(Newsfile Corp. - August 6, 2026) - Jones Healthcare Group has acquired an operating thermoforming facility and related business assets in Brampton, Ont., adding in-house production of custom-formed packaging components to its integrated offering. The acquisition includes the facility, equipment and an experienced team of colleagues who will join Jones Healthcare. The addition complements the company's existing expertise in printed packaging components, contract packagi
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 10:30 AM EDT | Jones Healthcare Group
Joseph N. Savasta Named 2026 PBMI Innovator Award Recipient
New York, New York--(Newsfile Corp. - August 6, 2026) - HarmonyRx is proud to announce that its Chief Executive Officer, Joseph N. Savasta, has been selected as a recipient of the 2026 PBMI Innovator Award, presented by the Pharmacy Benefit Management Institute (PBMI) and Managed Healthcare Executive. The PBMI Innovator Award recognizes individuals who are driving meaningful change within the pharmacy benefits industry through innovation, leadership and a commitment to imp
2026-08-06 9:10 AM EDT | HarmonyRx
NuGen Announces Non-Binding LOI to Acquire Sol-Millennium Canada
Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce it has entered a non-binding letter of intent ("LOI") with Sol-Millennium Medical HK Limited ("SolM HK"), the sole shareholder of Sol-Millenium Canada Inc. ("SolM"), dated August 5, 2026 to acquire all of the issued and outstanding common shares of SolM (the "Proposed Transaction"). Each party is curre
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 8:07 AM EDT | NuGen Medical Devices Inc.
Cheelcare Invited to Numotion Commercial Growth Summit
Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has been invited to participate in the Numotion Commercial Growth Summit, scheduled for August 12-14, 2026, in Denver, Colorado. The Commercial Growth Summit brings together clinicians, Assistive Technology Professionals (ATP's), regional decision-makers, and industry leaders from acros
2026-08-06 7:30 AM EDT | Cheelcare Inc.
Rise Nano Optics Ltd. Announces AGSM Results
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company"), is pleased to announce that all resolutions were passed at the annual general and special meeting of shareholders (the "AGSM") held yesterday in person at 10:00 am (Pacific Time). Annual General and Special Meeting Results A total of 16,027,785 common shares in the capital of the Company ("Common Shares
2026-08-06 7:00 AM EDT | Rise Nano Optics Ltd.
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will host a private dinner for physicians and investors on Wednesday, August 5, 2026, at 7:00 PM at Christner's Steakhouse.
Healthcare and Hospitals, Health
2026-08-05 4:30 PM EDT | Adia Med Inc.